tradingkey.logo

Greenwich Lifesciences Inc <GLSI.OQ> expected to post a loss of 24 cents a share - Earnings Preview

ReutersAug 8, 2025 9:33 PM
  • Greenwich Lifesciences Inc GLSI.OQ GLSI.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Greenwich Lifesciences Inc is for a loss of 24 cents per share.

  • The one available analyst rating on the shares is "buy".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Greenwich Lifesciences Inc is $39.00, about 70.1% above its last closing price of $11.67

This summary was machine generated August 8 at 21:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI